118 related articles for article (PubMed ID: 1396043)
21. Differential activation of the c-Ki-ras-2 proto-oncogene in human colorectal carcinoma.
Halatsch ME; Hirsch-Ernst KI; Weinel RJ; Kahl GF
Anticancer Res; 1998; 18(4A):2323-5. PubMed ID: 9703874
[TBL] [Abstract][Full Text] [Related]
22. Enhanced expression of c-myc and epidermal growth factor receptor (C-erbB-1) genes in primary human renal cancer.
Yao M; Shuin T; Misaki H; Kubota Y
Cancer Res; 1988 Dec; 48(23):6753-7. PubMed ID: 2460228
[TBL] [Abstract][Full Text] [Related]
23. [A study on expression of various oncogenes and tumor-associated genes in LEC rats spontaneously developing hepatitis and hepatoma].
Suzuki H
Hokkaido Igaku Zasshi; 1990 Mar; 65(2):201-9. PubMed ID: 1694810
[TBL] [Abstract][Full Text] [Related]
24. [Expression of oncogenes C-myc, C-raf and N-ras in advanced cancers of the upper respiratory and digestive tracts. Correlation with tumor clinical response to chemotherapy].
Reyt E; Lavieille JP; Brambilla E; Barra Y; Riva C
Ann Otolaryngol Chir Cervicofac; 1993; 110(6):310-5. PubMed ID: 8210089
[TBL] [Abstract][Full Text] [Related]
25. Suppression of Ki-ras p21 levels leading to growth inhibition of pancreatic cancer cell lines with Ki-ras mutation but not those without Ki-ras mutation.
Aoki K; Yoshida T; Matsumoto N; Ide H; Sugimura T; Terada M
Mol Carcinog; 1997 Oct; 20(2):251-8. PubMed ID: 9364215
[TBL] [Abstract][Full Text] [Related]
26. Activation of the proto-oncogene c-myc and c-fos by c-ras: involvement of polyamines.
Tabib A; Bachrach U
Biochem Biophys Res Commun; 1994 Jul; 202(2):720-7. PubMed ID: 8048943
[TBL] [Abstract][Full Text] [Related]
27. p53, Ki-ras, and DNA ploidy in human pancreatic ductal adenocarcinomas.
Weyrer K; Feichtinger H; Haun M; Weiss G; Ofner D; Weger AR; Umlauft F; Grünewald K
Lab Invest; 1996 Jan; 74(1):279-89. PubMed ID: 8569192
[TBL] [Abstract][Full Text] [Related]
28. Amplifications of proto-oncogenes in ovarian carcinoma.
Bian M; Fan Q; Huang S; Ma J; Lang J
Chin Med J (Engl); 1995 Nov; 108(11):844-8. PubMed ID: 8585978
[TBL] [Abstract][Full Text] [Related]
29. Mutations in the Kirsten-ras oncogene are common but lack correlation with prognosis and tumor stage in human pancreatic carcinoma.
Motojima K; Urano T; Nagata Y; Shiku H; Tsunoda T; Kanematsu T
Am J Gastroenterol; 1991 Dec; 86(12):1784-8. PubMed ID: 1962623
[TBL] [Abstract][Full Text] [Related]
30. Amplification and activation of c-Ki-ras oncogene in cell line developed from human pancreas explants.
Maheshwari KK; Parsa I
Biochem Int; 1991 Sep; 25(2):233-40. PubMed ID: 1789790
[TBL] [Abstract][Full Text] [Related]
31. Aberrant oncogene expression in uncultured human sarcoma and melanoma.
Shin DM; Gupta V; Donner L; Chawla S; Benjamin R; Gutterman J; Blick M
Anticancer Res; 1987; 7(6):1117-23. PubMed ID: 3442409
[TBL] [Abstract][Full Text] [Related]
32. Clonal cosegregation of tumorigenicity with overexpression of c-myc and transforming growth factor alpha genes in chemically transformed rat liver epithelial cells.
Lee LW; Raymond VW; Tsao MS; Lee DC; Earp HS; Grisham JW
Cancer Res; 1991 Oct; 51(19):5238-44. PubMed ID: 1717143
[TBL] [Abstract][Full Text] [Related]
33. [Characterization of oncogenes (K, N-ras and N, c-myc) in subcloned cell lines (KCC-1a and 1b) derived from same endometrial carcinoma presenting well differentiated adenocarcinoma and clear cell carcinoma].
Kataoka A; Yakushiji M; Ohbuchi T; Morimitsu Y; Kojiro M
Nihon Sanka Fujinka Gakkai Zasshi; 1991 Oct; 43(10):1317-22. PubMed ID: 1955783
[TBL] [Abstract][Full Text] [Related]
34. [The inhibitory effect of antisense oligodeoxynucleotides on the growth of human pancreatic adenocarcinoma cell lines].
Liu TH
Zhonghua Bing Li Xue Za Zhi; 1993 Feb; 22(1):25-9. PubMed ID: 8330327
[TBL] [Abstract][Full Text] [Related]
35. [Immunohistological study on ras and myc oncogene products in pancreatic cancer].
Motoshima K; Kohara N; Shiogama T; Fujii M; Nakago S; Tsunoda T; Nagata Y
Nihon Geka Gakkai Zasshi; 1990 Jan; 91(1):123-9. PubMed ID: 2138243
[TBL] [Abstract][Full Text] [Related]
36. Expression of c-myc and c-Ha-ras oncogenes in human lymphoblastoid cells (Namalva).
Mahmoudi M; Motoo Y; Vela GR; Bollon AP; Osther K
Cell Mol Biol; 1989; 35(1):75-80. PubMed ID: 2650877
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of c-Ki-ras and c-fos in human pancreatic carcinomas.
Wakita K; Ohyanagi H; Yamamoto K; Tokuhisa T; Saitoh Y
Int J Pancreatol; 1992 Feb; 11(1):43-7. PubMed ID: 1583354
[TBL] [Abstract][Full Text] [Related]
38. [The inhibitory effect of combined treatment of TNF alpha and antisense oligodeoxynucleotides on the growth of human pancreatic carcinoma cell line cells].
Zhang L; Guo H; Liu T
Zhonghua Bing Li Xue Za Zhi; 1997 Oct; 26(5):281-4. PubMed ID: 10374336
[TBL] [Abstract][Full Text] [Related]
39. Resistance of human larynx carcinoma cells to cisplatin, gamma-irradiation and methotrexate does not involve overexpression of c-myc or c-Ki-ras oncogenes.
Osmak M; Beketić-Oresković L; Matulić M; Sorić J
Mutat Res; 1993 Nov; 303(3):113-20. PubMed ID: 7694127
[TBL] [Abstract][Full Text] [Related]
40. [Inhibition of cell growth and target gene expression of human pancreatic carcinoma cells by modified antisense oligodeoxynucleotide].
Liu T; Wang Z; Zhang L
Zhonghua Bing Li Xue Za Zhi; 1997 Jun; 26(3):147-51. PubMed ID: 10072855
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
